Accuracy of Non-Invasive Blood Pressure Measurement in Adults

Hypertension Clinical Trial

— NIBP  

Official title:

Clinical Evaluation of the Sotera VisiTM System for Measurement of Systolic and Diastolic Blood Pressures in Adults

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT01183741
• Other study ID #: SOW-US10-003
• Secondary ID: 0-00026
• Status: Withdrawn
• Phase: Phase 3
• First received: August 13, 2010
• Last updated: June 21, 2011
• Start date: September 2010
• Est. completion date: October 2010

Study information

• Verified date: June 2011
• Source: Sotera Wireless, Inc.
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to compare the accuracy of the Sotera ViSi, an investigational device, to auscultation (measurement with a cuff) in determining systolic and diastolic blood pressure (BP) in adult subjects.

Description:

This study is a single-center blinded study that will enroll approximately 150 adult subjects. Trained auscultators will perform the standard auscultation BP measurements. They will be blinded to each other's measurements and from the ViSi measurements.

The study population will be randomized into two groups based on the side of the blood pressure measurement: the left arm group (LAG) and the right arm group (RAG).

The randomization ratio of the LAG and RAG will be 1:1. There will be forced stratification in order to ensure that the study subjects meet the required arm circumference and blood pressure distributions as specified in the SP10:2008 and ISO 81060-2:2009(E) standards.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 150
• Est. completion date: October 2010
• Est. primary completion date: October 2010
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 12 Years and older

Eligibility

Inclusion Criteria:

• Subject is greater than 12 years of age at the time of screening.

• Subject's upper arm circumference is between 20cm and 55cm.

• Subject is willing to undergo the Informed Consent process prior to enrollment in the study.

• Subject is willing and able to participate for up to 60 minutes.

Exclusion Criteria:

• Subject is participating in another clinical study that may interfere with the results of this study.

• Subject is unable to have a blood pressure measurement taken from either arm for any reason.

• Subject is evaluated by the Investigator and found to be medically unsuitable for participation in this study.

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Hypertension
• Hypotension

Locations

Country	Name	City	State
United States	Scripps Clinic Rancho Bernardo	San Diego	California

Sponsors (1)

Lead Sponsor	Collaborator
Sotera Wireless, Inc.

Country where clinical trial is conducted

United States,